期刊
AMERICAN JOURNAL OF HUMAN GENETICS
卷 107, 期 6, 页码 1149-1156出版社
CELL PRESS
DOI: 10.1016/j.ajhg.2020.10.013
关键词
-
资金
- National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL116352]
- National Institute of General Medical Sciences [R01GM110628]
- Cincinnati Children's Hospital CPG (Center for Pediatric Genomics)
- Cincinnati Children's Hospital CuSTOM (Center for Stem Cell & Organoid Medicine)
- NIH [P41-GM103311]
The Congenital Dyserythropoietic Anemia (CDA) Registry was established with the goal to facilitate investigations of natural history, biology, and molecular pathogenetic mechanisms of CDA. Three unrelated individuals enrolled in the registry had a syndrome characterized by CDA and severe neurodevelopmental delay. They were found to have missense mutations in VPS4A, a gene coding for an ATPase that regulates the ESCRT-III machinery in a variety of cellular processes including cell division, endosomal vesicle trafficking, and viral budding. Bone marrow studies showed binucleated erythroblasts and erythroblasts with cytoplasmic bridges indicating abnormal cytokinesis and abscission. Circulating red blood cells were found to retain transferrin receptor (CD71) in their membrane, demonstrating that VPS4A is critical for normal reticulocyte maturation. Using proband-derived induced pluripotent stem cells (iPSC5), we have successfully modeled the hematologic aspects of this syndrome in vitro, recapitulating their dyserythropoietic phenotype. Our findings demonstrate that VPS4A mutations cause cytokinesis and trafficking defects leading to a human disease with detrimental effects to erythropoiesis and neurodevelopment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据